Research progress on circulating tumor cells and their detection in colorectal cancer

doi:10.3969/j.issn.1007-3969.2015.11.003

China Oncology ›› 2015, Vol. 25 ›› Issue (11): 854-860.doi: 10.3969/j.issn.1007-3969.2015.11.003

Previous Articles Next Articles

Research progress on circulating tumor cells and their detection in colorectal cancer

SUN Wenjie, ZHANG Zhen

Department of Radiation Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Online:2015-11-30 Published:2016-02-01
Contact: ZHANG Zhen E-mail: zhenzhang6@gmail.com

Abstract

Abstract: Colorectal cancer is one of the most common malignant tumors. Though the development of multidisciplinary therapy has largely improved the therapy effects, many patients still died of local recurrence and metastases after surgery. Circulating tumor cell (CTC) originates from primary tumor tissues and has a close
relationship with cancer metastases and prognosis. This review summarizes the CTC detection methods and relevant clinical research on CTC in recent years.

Key words: Colorectal cancer, Circulating tumor cell, Detection, Therapy

SUN Wenjie, ZHANG Zhen. Research progress on circulating tumor cells and their detection in colorectal cancer[J]. China Oncology, 2015, 25(11): 854-860.

[1]	JIA Zhenzhen, HE Shuang, LI Yangyang, WEN Feifei, XU Xiaoyang, GUO Ningjie, WU Shuhua. Correlations between expressions of DPD, LC3 and P62 in colorectal cancer and their clinical significance [J]. China Oncology, 2022, 32(1): 24-33.
[2]	YANG Yanju, ZHONG Yang, HU Weigang, GAO Dadi, ZHAO Jun. Effects of CT-RED calibration curves of different simulators on dose distribution of tumor target and organs at risk [J]. China Oncology, 2021, 31(9): 828-837.
[3]	MA Yifei , LIANG Xinjun , WEI Shaozhong . Prognostic value of inflammatory and immune markers in resectable colorectal cancer [J]. China Oncology, 2021, 31(9): 845-851.
[4]	CONG Binbin, WANG Yongsheng. Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer [J]. China Oncology, 2021, 31(8): 689-696.
[5]	ZHU Yihui, LI Ting, HU Xichun. Clinical research progress and prospect of trastuzumab deruxtecan [J]. China Oncology, 2021, 31(8): 754-761.
[6]	ZHANG Yingqiang , LIN Yansong . Application and research progress of ⁹⁰Y microspheres internal radiation therapy in colorectal cancer with liver metastasis [J]. China Oncology, 2021, 31(8): 762-768.
[7]	XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia. The advances in immunotherapy biomarkers of small cell lung cancer [J]. China Oncology, 2021, 31(7): 635-639.
[8]	LI Wei, ZHANG Shanling, TAO Yingjie, WANG Xudong. Research status and progress of mechanism of T cell immune metabolism and its application combined with immune checkpoint inhibitor [J]. China Oncology, 2021, 31(7): 640-646.
[9]	HUA Qing, SHEN Xuefang, XU Pingbo . Effect of KLK8 on apoptosis of colorectal cancer cells by regulating EGF and its mechanism [J]. China Oncology, 2021, 31(5): 383-389.
[10]	MA Weidong, WANG Tongtong, ZHU Qihang, YANG Haiou, LIN Dan. Mechanism of colorectal cancer cell exosome-derived circ_0044366 in regulating release of MMP2 in fibroblasts and promoting metastasis of colorectal cancer [J]. China Oncology, 2021, 31(5): 397-407.
[11]	NIU Na, LIN Yansong. Application and research progress of selective internal radiation therapy with ⁹⁰ Y microspheres in hepatocellular carcinoma [J]. China Oncology, 2021, 31(5): 428-434.
[12]	ZHU Jun, WU Xiaohua. Leading research progress and prospect of gynecological oncology in 2020 [J]. China Oncology, 2021, 31(4): 250-256.
[13]	ZHU Junjun, GE Naijian, YANG Yefa. Current status and prospects of migration of radioactive 125 I seed implanted in malignant tumor [J]. China Oncology, 2021, 31(4): 257-262.
[14]	ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang . A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma [J]. China Oncology, 2021, 31(4): 294-301.
[15]	CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin. Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases [J]. China Oncology, 2021, 31(4): 330-334.

Research progress on circulating tumor cells and their detection in colorectal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments